LBPH שווי מלא של הפעילות העסקית Longboard

Longboard Pharmaceuticals specializes in developing epilepsy treatments, leveraging partnerships with scientific centers to accelerate commercialization. Market price action on GURU.Markets shows an Enterprise Value of . The high business valuation is driven by patents and promising bexicaserin trials, making the company's biotechnological foundation one of the most defensive assets in its segment.

For the research-intensive biotech Longboard Pharmaceuticals (LBPH), which attracts neurobiologists through stock options and premium payouts, this indicator reflects the aggregate value of intellectual capital and infrastructure. Analyzing the core business value, an investor sees the actual acquisition price of Longboard Pharmaceuticals (LBPH) via the sum of market capitalization and debt minus cash, allowing for an assessment of the asset's fundamental value adjusted for net debt.